These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32588793)

  • 41. BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present.
    Marotta V; Guerra A; Zatelli MC; Uberti ED; Di Stasi V; Faggiano A; Colao A; Vitale M
    Clin Endocrinol (Oxf); 2013 Nov; 79(5):733-8. PubMed ID: 23469895
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hashimoto's thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer.
    Marotta V; Sciammarella C; Chiofalo MG; Gambardella C; Bellevicine C; Grasso M; Conzo G; Docimo G; Botti G; Losito S; Troncone G; De Palma M; Giacomelli L; Pezzullo L; Colao A; Faggiano A
    Endocr Relat Cancer; 2017 Sep; 24(9):485-493. PubMed ID: 28696209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. IL-10 Restores MHC Class I Expression and Interferes With Immunity in Papillary Thyroid Cancer With Hashimoto Thyroiditis.
    Lu ZW; Hu JQ; Liu WL; Wen D; Wei WJ; Wang YL; Wang Y; Liao T; Ji QH
    Endocrinology; 2020 Oct; 161(10):. PubMed ID: 32348468
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical relationship between Hashimoto's thyroiditis and papillary thyroid cancer.
    Ahn D; Heo SJ; Park JH; Kim JH; Sohn JH; Park JY; Park SK; Park J
    Acta Oncol; 2011 Nov; 50(8):1228-34. PubMed ID: 21871002
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discriminatory ability of fractal and grey level co-occurrence matrix methods in structural analysis of hippocampus layers.
    Pantic I; Dacic S; Brkic P; Lavrnja I; Jovanovic T; Pantic S; Pekovic S
    J Theor Biol; 2015 Apr; 370():151-6. PubMed ID: 25665716
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Soluble DPP4 can act as a diagnostic biomarker in Hashimoto's thyroiditis with thyroid papillary carcinoma.
    Zhang Y; Zhang Q; Zheng Y; Chen J; Liu N; Liu K; Song W
    J Cancer Res Ther; 2023 Aug; 19(4):1048-1054. PubMed ID: 37675735
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Coexistence of papillary carcinoma and Hashimoto's thyroiditis.
    Matesa-Anić D; Matesa N; Dabelić N; Kusić Z
    Acta Clin Croat; 2009 Mar; 48(1):9-12. PubMed ID: 19623865
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinico-pathological features of papillary thyroid cancer coexistent with Hashimoto's thyroiditis].
    Molnár S; Győry F; Nagy E; Méhes G; Molnár C
    Orv Hetil; 2017 Feb; 158(5):178-182. PubMed ID: 28132543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Important cytological findings for distinction between follicular variant and conventional papillary thyroid carcinoma, including noninvasive follicular thyroid tumors with papillary-like nuclear features.
    Koshikawa T; Fujita N; Ueda N; Ota Y; Sasaki E; Murakami Y; Hosoda W; Yatabe Y; Hanai N; Higuchi M; Hirokawa M; Miyauchi A
    Endocr J; 2019 May; 66(5):475-483. PubMed ID: 30867345
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oncocytic variant of papillary thyroid carcinoma associated with Hashimoto's thyroiditis: a case report and review of the literature.
    Lee J; Hasteh F
    Diagn Cytopathol; 2009 Aug; 37(8):600-6. PubMed ID: 19526577
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical and pathological differences between papillary thyroid carcinoma with Graves' disease and papillary thyroid carcinoma with Hashimoto's thyroiditis].
    Xu DD; Lun Y; Liu X; Jiang H; Song JB; Duan ZQ; Xin SJ; Zhang J
    Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(32):2491-2495. PubMed ID: 28835054
    [No Abstract]   [Full Text] [Related]  

  • 52. Interleukin-17 and vascular endothelial growth factor: new biomarkers for the diagnosis of papillary thyroid carcinoma in patients with Hashimoto's thyroiditis.
    Li S; Li S; Lin M; Li Z; He J; Qiu J; Zhang J
    J Int Med Res; 2022 Jan; 50(1):3000605211067121. PubMed ID: 35023376
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hashimoto's thyroiditis and papillary thyroid carcinoma. Are cytokeratin 19 and P63 proteins of any diagnostic value?
    Divani SN; Kalodimos GP; Lioupis MA; Syrmos NC
    Hell J Nucl Med; 2016; 19(3):250-253. PubMed ID: 27824965
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical Review: Hashimoto's thyroiditis and papillary thyroid carcinoma: is there a correlation?
    Jankovic B; Le KT; Hershman JM
    J Clin Endocrinol Metab; 2013 Feb; 98(2):474-82. PubMed ID: 23293329
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic value of CD56 immunohistochemistry in thyroid lesions.
    Pyo JS; Kim DH; Yang J
    Int J Biol Markers; 2018 May; 33(2):161-167. PubMed ID: 29799356
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The clinicopathologic differences of central lymph node metastasis in predicting lateral lymph node metastasis and prognosis in papillary thyroid cancer associated with or without Hashimoto's thyroiditis.
    Zhu Y; Zheng K; Zhang H; Chen L; Xue J; Ding M; Wu K; Wang Z; Kong L; Chen X
    Tumour Biol; 2016 Jun; 37(6):8037-45. PubMed ID: 26711787
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Concomitant papillary thyroid carcinoma and Hashimoto's thyroiditis.
    Liu LH; Bakhos R; Wojcik EM
    Semin Diagn Pathol; 2001 May; 18(2):99-103. PubMed ID: 11403259
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Papillary Thyroid Carcinoma Emerging from Hashimoto Thyroiditis Demonstrates Increased PD-L1 Expression, Which Persists with Metastasis.
    Lubin D; Baraban E; Lisby A; Jalali-Farahani S; Zhang P; Livolsi V
    Endocr Pathol; 2018 Dec; 29(4):317-323. PubMed ID: 30121940
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis.
    Lun Y; Wu X; Xia Q; Han Y; Zhang X; Liu Z; Wang F; Duan Z; Xin S; Zhang J
    Otolaryngol Head Neck Surg; 2013 Mar; 148(3):396-402. PubMed ID: 23300224
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis.
    Kim SK; Song KH; Lim SD; Lim YC; Yoo YB; Kim JS; Hwang TS
    Thyroid; 2009 Feb; 19(2):137-41. PubMed ID: 19014278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.